TCM
Tang Capital Management Portfolio holdings
AUM
$1.98B
1-Year Return
21.62%
This Quarter Return
-5.03%
1 Year Return
+21.62%
3 Year Return
+290.69%
5 Year Return
+284.46%
10 Year Return
+928.34%
AUM
$1.81B
AUM Growth
+$296M
(+20%)
Cap. Flow
+$419M
Cap. Flow
% of AUM
23.17%
Top 10 Holdings %
Top 10 Hldgs %
39.2%
Holding
208
New
25
Increased
78
Reduced
31
Closed
6
Top Buys
| 1 |
Dynavax Technologies
DVAX
|
$50.6M |
| 2 |
Galapagos
GLPG
|
$45.2M |
| 3 |
Kiniksa Pharmaceuticals
KNSA
|
$33.1M |
| 4 |
Spyre Therapeutics
SYRE
|
$33.1M |
| 5 |
SLRN
ACELYRIN
SLRN
|
$24.3M |
Top Sells
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$10.6M |
| 2 |
OMIC
Singular Genomics Systems, Inc. Common Stock
OMIC
|
$7.23M |
| 3 |
GRAL
GRAIL, Inc. Common Stock
GRAL
|
$4.82M |
| 4 |
ALMS
Alumis Inc. Common Stock
ALMS
|
$4.72M |
| 5 |
Seer Inc
SEER
|
$1.52M |
Sector Composition
| 1 | Healthcare | 94.79% |
| 2 | Technology | 1.25% |
| 3 | Communication Services | 1.23% |
| 4 | Consumer Discretionary | 0.99% |
| 5 | Financials | 0.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Microsoft
MSFT
$3.78T
| $1.81M | 0.1% |
4,825
+1,412
| +41% | +$530K |
|
127
Home Depot
HD
$410B
| $1.78M | 0.1% |
4,850
+1,497
| +45% | +$549K |
|
128
CareDx
CDNA
$697M
| $1.78M | 0.1% |
100,000
| – | – |
|
129
Texas Instruments
TXN
$170B
| $1.76M | 0.1% |
9,775
+3,207
| +49% | +$576K |
|
|
OKUR
130
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$36.4M
| $1.72M | 0.1% |
400,000
+105,374
| +36% | +$453K |
|
131
Pfizer
PFE
$140B
| $1.69M | 0.09% |
66,800
+23,892
| +56% | +$605K |
|
132
Erasca
ERAS
$420M
| $1.63M | 0.09% |
1,190,012
+587,097
| +97% | +$804K |
|
133
Verastem
VSTM
$650M
| $1.63M | 0.09% |
270,000
| – | – |
|
134
Nike
NKE
$111B
| $1.57M | 0.09% |
24,764
+8,975
| +57% | +$570K |
|
135
Bolt Biotherapeutics
BOLT
$9.29M
| $1.53M | 0.08% |
190,639
| – | – |
|
136
Fate Therapeutics
FATE
$112M
| $1.48M | 0.08% |
1,867,773
+11,819
| +0.6% | +$9.34K |
|
137
Viatris
VTRS
$12B
| $1.47M | 0.08% |
168,979
+54,663
| +48% | +$476K |
|
138
PayPal
PYPL
$65.4B
| $1.44M | 0.08% |
22,108
+6,394
| +41% | +$417K |
|
139
C4 Therapeutics
CCCC
$190M
| $1.44M | 0.08% |
900,000
| – | – |
|
140
Neumora Therapeutics
NMRA
$264M
| $1.4M | 0.08% |
+1,400,000
| New | +$1.4M |
|
|
ELEV
141
DELISTED
Elevation Oncology
ELEV
| $1.23M | 0.07% |
4,760,000
| – | – |
|
|
CLYM
142
Climb Bio, Inc. Common Stock
CLYM
$158M
| $1.22M | 0.07% |
+1,000,000
| New | +$1.22M |
|
143
Netflix
NFLX
$534B
| $1.21M | 0.07% |
1,301
-43
| -3% | -$40.1K |
|
144
Applied Therapeutics
APLT
$67M
| $1.19M | 0.07% |
2,428,169
| – | – |
|
145
Aligos Therapeutics
ALGS
$74.7M
| $1.16M | 0.06% |
+141,131
| New | +$1.16M |
|
146
T-Mobile US
TMUS
$284B
| $1.15M | 0.06% |
4,328
-181
| -4% | -$48.3K |
|
147
GE Aerospace
GE
$299B
| $1.14M | 0.06% |
5,675
-236
| -4% | -$47.2K |
|
|
KRON
148
DELISTED
Kronos Bio
KRON
| $1.11M | 0.06% |
1,345,413
+342,031
| +34% | +$282K |
|
149
Pyxis Oncology
PYXS
$99.8M
| $1.08M | 0.06% |
+1,100,000
| New | +$1.08M |
|
150
Allstate
ALL
$54.9B
| $1.06M | 0.06% |
5,112
-207
| -4% | -$42.9K |
|